Forkhead box protein p 1 is a transcriptional repressor of immune signaling in the CNS : implications for transcriptional dysregulation in Huntington disease
暂无分享,去创建一个
Brian Spencer | E. Masliah | B. Leavitt | B. Spencer | E. Thomas | B. Tang | Eliezer Masliah | Blair R Leavitt | Colum Connolly | C. Connolly | Paula A. Desplats | Elizabeth A Thomas | Bin Tang | Kristina Becanovic | Paula A Desplats | Austin M Hill | K. Bečanović | A. Hill | Colúm Connolly | Bin Tang | E. Thomas
[1] D. Dickson,et al. Expanded-Polyglutamine Huntingtin Protein Suppresses the Secretion and Production of a Chemokine (CCL5/RANTES) by Astrocytes , 2008, The Journal of Neuroscience.
[2] Chuan-en Wang,et al. Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms , 2009, Proceedings of the National Academy of Sciences.
[3] Terence P. Speed,et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..
[4] M. Mattson,et al. NF-kappaB in neuronal plasticity and neurodegenerative disorders. , 2001, The Journal of clinical investigation.
[5] K. Asadullah,et al. Interleukin-10 Therapy—Review of a New Approach , 2003, Pharmacological Reviews.
[6] S. Ziegler,et al. Scurfin (FOXP3) Acts as a Repressor of Transcription and Regulates T Cell Activation* , 2001, The Journal of Biological Chemistry.
[7] R. Ferrante,et al. Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.
[8] A. Hamby,et al. Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[9] A. Monaco,et al. Identification of FOXP1 Deletions in Three Unrelated Patients with Mental Retardation and Significant Speech and Language Deficits , 2010, Human mutation.
[10] C Fidler,et al. The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. , 2001, Cancer research.
[11] D. Kleinjan,et al. Long-range control of gene expression: emerging mechanisms and disruption in disease. , 2005, American journal of human genetics.
[12] E. Thomas,et al. Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease , 2008, Neurobiology of Disease.
[13] Kaoru Takahashi,et al. Expression of Foxp2, a gene involved in speech and language, in the developing and adult striatum , 2003, Journal of neuroscience research.
[14] S. Mémet,et al. NF-κB functions in the nervous system: From development to disease , 2006 .
[15] T. van der Poll,et al. Proinflammatory Effects of IL-10 During Human Endotoxemia1 , 2000, The Journal of Immunology.
[16] D. Geschwind,et al. In vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons. , 2011, Human molecular genetics.
[17] Clifford A. Meyer,et al. Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.
[18] M. Greene,et al. FOXP3 Actively Represses Transcription by Recruiting the HAT/HDAC Complex , 2007, Cell cycle.
[19] Coordinated Actions of the Forkhead Protein Foxp1 and Hox Proteins in the Columnar Organization of Spinal Motor Neurons , 2008, Neuron.
[20] T. Prolla,et al. Evolution of the Aging Brain Transcriptome and Synaptic Regulation , 2008, PloS one.
[21] L. Staudt,et al. Decision making in the immune system: Lymphoid Malignancies: the dark side of B-cell differentiation , 2002, Nature Reviews Immunology.
[22] J. Buhler,et al. Quantitative assessment of transcriptome differences between brain territories. , 2003, Genome research.
[23] Y. Xing,et al. A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function , 2008, The Journal of Neuroscience.
[24] Mauro Delorenzi,et al. Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. , 2007, Human molecular genetics.
[25] K. Davies,et al. Functional genetic analysis of mutations implicated in a human speech and language disorder. , 2006, Human molecular genetics.
[26] P G Bhide,et al. Early and Progressive Accumulation of Reactive Microglia in the Huntington Disease Brain , 2001, Journal of neuropathology and experimental neurology.
[27] Ji-Yeon Shin,et al. Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity , 2005, The Journal of cell biology.
[28] T. Chatila,et al. FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease. , 2007, International immunology.
[29] I. Verma,et al. Design and cloning of lentiviral vectors expressing small interfering RNAs , 2006, Nature Protocols.
[30] T. Jessell,et al. Hox Repertoires for Motor Neuron Diversity and Connectivity Gated by a Single Accessory Factor, FoxP1 , 2008, Cell.
[31] P. Patterson,et al. Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[32] D. Geschwind,et al. Gene expression profiling of R6/2 transgenic mice with different CAG repeat lengths reveals genes associated with disease onset and progression in Huntington's disease , 2011, Neurobiology of Disease.
[33] S. Barger,et al. S100B‐induced microglial and neuronal IL‐1 expression is mediated by cell type‐specific transcription factors , 2005, Journal of neurochemistry.
[34] Bin Wang,et al. Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation , 2004, Development.
[35] Manish S. Shah,et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.
[36] S. Tabrizi,et al. Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates. , 2007, Journal of proteome research.
[37] G. Bing,et al. Glial cell line-derived neurotrophic factor protects midbrain dopaminergic neurons against lipopolysaccharide neurotoxicity , 2010, Journal of Neuroimmunology.
[38] C. Röpke,et al. Suppressors of cytokine signalling: SOCS , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[39] A. Monaco,et al. A forkhead-domain gene is mutated in a severe speech and language disorder , 2001, Nature.
[40] Brian C. Jackson,et al. Update of human and mouse forkhead box (FOX) gene families , 2010, Human Genomics.
[41] Maria Jansson,et al. Targeted transgene expression in rat brain using lentiviral vectors , 2003, Journal of neuroscience research.
[42] H. Boddeke,et al. Neuronal Chemokines: Versatile Messengers In Central Nervous System Cell Interaction , 2007, Molecular Neurobiology.
[43] J. Olson,et al. Regional and cellular gene expression changes in human Huntington's disease brain. , 2006, Human molecular genetics.
[44] S. Rogers,et al. Neuronal expression of tumor necrosis factor alpha in the murine brain. , 1996, Neuroimmunomodulation.
[45] D. Dean,et al. Rb Interacts with Histone Deacetylase to Repress Transcription , 1998, Cell.
[46] P. Carlsson,et al. Forkhead transcription factors: key players in development and metabolism. , 2002, Developmental biology.
[47] M. Hayden,et al. Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis. , 2010, Human molecular genetics.
[48] Claire-Anne Gutekunst,et al. A YAC Mouse Model for Huntington’s Disease with Full-Length Mutant Huntingtin, Cytoplasmic Toxicity, and Selective Striatal Neurodegeneration , 1999, Neuron.
[49] S. Rutz,et al. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. , 2011, Annual review of immunology.
[50] N. Sykes,et al. Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits. , 2005, American journal of human genetics.
[51] J. Nardone,et al. Foxp1 is an essential transcriptional regulator of B cell development , 2006, Nature Immunology.
[52] M. Hayden,et al. A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease , 2008, The Journal of experimental medicine.
[53] P. Patterson,et al. Activation of the IκB Kinase Complex and Nuclear Factor-κB Contributes to Mutant Huntingtin Neurotoxicity , 2004, The Journal of Neuroscience.
[54] Gordon K Smyth,et al. Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .
[55] Christopher A Walsh,et al. Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain , 2003, The Journal of comparative neurology.
[56] E. Fombonne,et al. De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment. , 2010, American journal of human genetics.
[57] D J Brooks,et al. Microglial activation correlates with severity in Huntington disease , 2006, Neurology.
[58] C. Ballantyne,et al. Integrin engagement regulates monocyte differentiation through the forkhead transcription factor Foxp1. , 2004, The Journal of clinical investigation.
[59] D. Rubinsztein,et al. Transcriptional abnormalities in Huntington disease. , 2003, Trends in genetics : TIG.
[60] S. Mémet. NF-kappaB functions in the nervous system: from development to disease. , 2006, Biochemical pharmacology.
[61] Weiguo Shu,et al. Characterization of a New Subfamily of Winged-helix/Forkhead (Fox) Genes That Are Expressed in the Lung and Act as Transcriptional Repressors* , 2001, The Journal of Biological Chemistry.
[62] E. Thomas,et al. Striatal specificity of gene expression dysregulation in Huntington's disease , 2006, Journal of neuroscience research.
[63] Yen F. Tai,et al. Imaging microglial activation in Huntington's disease , 2007, Brain Research Bulletin.
[64] M. MacDonald,et al. Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. , 2000, Human molecular genetics.
[65] Hwan-Suck Chung,et al. Foxp3 is a novel repressor of microglia activation , 2010, Glia.
[66] J. Sutcliffe,et al. Selective deficits in the expression of striatal‐enriched mRNAs in Huntington's disease , 2006, Journal of neurochemistry.
[67] W. Alexander,et al. The suppressors of cytokine signalling (SOCS) , 2001, Cellular and Molecular Life Sciences CMLS.
[68] E. Masliah,et al. Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in α-Synuclein Models of Parkinson's and Lewy Body Diseases , 2009, The Journal of Neuroscience.
[69] T. Speed,et al. Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.
[70] P. Musiani,et al. IL‐6 Expression in Neurons of Transgenic Mice Causes Reactive Astrocytosis and Increase in Ramified Microglial Cells but no Neuronal Damage , 1995, The European journal of neuroscience.
[71] Alexander Gerhard,et al. Microglial activation in presymptomatic Huntington's disease gene carriers. , 2005, Brain : a journal of neurology.
[72] G. Ippolito,et al. Foxp1 is an essential transcriptional regulator for the generation of quiescent naive T cells during thymocyte development. , 2010, Blood.
[73] Mark P. Mattson,et al. NF-κB in neuronal plasticity and neurodegenerative disorders , 2001 .
[74] E. Morrisey,et al. Coordinated Actions of the Forkhead Protein Foxp1 and Hox Proteins in the Columnar Organization of Spinal Motor Neurons , 2008, Neuron.
[75] E. Senba,et al. Expression pattern of the winged-helix/forkhead transcription factor Foxp1 in the developing central nervous system. , 2003, Gene expression patterns : GEP.